Core Viewpoint - The company, 希玛医疗, has agreed to sell 55% of its subsidiary 阿波罗 to 明达眼镜, which will involve the cancellation of a debt of 504.9 million RMB, thereby relieving the company of all liabilities related to this debt [1] Group 1: Transaction Details - The transaction will result in 阿波罗 no longer being a non-wholly owned subsidiary of the company, and the company will not hold any equity interest in 阿波罗 post-transaction [1] - The deal price includes the cancellation and return of previously issued bonds worth 504.9 million RMB [1] Group 2: Strategic Initiatives - The company has implemented several strategic measures, focusing on ophthalmic services in Hong Kong and mainland China, as well as dental and medical services in Shenzhen [1] - The sale aligns with the company's strategy to optimize internal resource utilization [1]
希玛医疗向明达眼镜出售阿波罗55%股权